<DOC>
	<DOC>NCT00303407</DOC>
	<brief_summary>To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care</brief_summary>
	<brief_title>Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<criteria>Cancer patients in palliative care Patients fully informed about their condition Signed informed consent No exclusion criteria Absence of advanced cancer Cancer previously cured Venous thromboembolism diagnosed within 6 months prior to inclusion Absence of discerning capacity Active antithrombotic treatment with heparins or coumarines Thrombocytopenia &lt;50G/l PTT &gt;45sec TP&lt;35% Active bleeding Renal failure &lt;20ml/min Past history of heparininduced thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>